Astera Labs Inc (ALAB) concluded trading on Tuesday at a closing price of $141.60, with 2.74 million shares of worth about $387.93 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 155.40% during that period and on December 24, 2024 the price saw a gain of about 4.45%. Currently the company’s common shares owned by public are about 158.56M shares, out of which, 116.16M shares are available for trading.
Stock saw a price change of 10.99% in past 5 days and over the past one month there was a price change of 38.83%. Over the period of past 52 weeks, stock dropped to lowest price of $36.22 but also hit the highest price of $138.14 during that period. The average intraday trading volume for Astera Labs Inc shares is 4.90 million. The stock is currently trading 17.42% above its 20-day simple moving average (SMA20), while that difference is up 44.97% for SMA50 and it goes to 105.89% higher than SMA200.
Astera Labs Inc (NASDAQ: ALAB) currently have 158.56M outstanding shares and institutions hold larger chunk of about 46.16% of that.
The stock has a current market capitalization of $23.46B. It has posted earnings per share of -$0.60 in the same period. It has Quick Ratio of 10.46 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALAB, volatility over the week remained 7.97% while standing at 6.74% over the month.
Stock’s fiscal year EPS is expected to rise by 700.71% while it is estimated to increase by 62.07% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on November 18, 2024 offering a Buy rating for the stock and assigned a target price of $120 to it. Coverage by Morgan Stanley stated Astera Labs Inc (ALAB) stock as an Overweight in their note to investors on September 04, 2024, suggesting a price target of $55 for the stock. On April 16, 2024, Evercore ISI Initiated their recommendations, while on April 15, 2024, Stifel Initiated their ratings for the stock with a price target of $81. Stock get a Buy rating from ROTH MKM on April 15, 2024.
